Log In
Print this Print this

Signature LTx

  Manage Alerts
Collapse Summary General Information
Company Asuragen Inc.
DescriptionSignature LTx v2.0 leukemia translocation panel
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose translocation-positive leukemias
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today